Evidence map›Paper›PMID 41282410›Full record

ArticleBioactive materials2026

Low addition of Er and Zn into biomedical magnesium with enhanced integrated properties for orthopedic applications:

Jianing Liu, Yulin Lin, Ming Wang, Dong Bian, Shan Yang, Shi Cheng, Hong Xia, Yu Zhang, Zhigang Xu, Yufeng Zheng

Abstract read
In one paragraph

Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jianing LiuDepartment of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, China.
Yulin LinDepartment of Orthopedics, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangdong, 510700, China.
Ming WangMusculoskeletal Research Laboratory, Department of Orthopaedics & Traumatology, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, 999077, Hong Kong.
Dong BianMedical Research Institute, Department of Orthopedics, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Shan YangGeneral Hospital of Southern Theatre Command of PLA, Guangzhou, 510010, China.
Shi ChengDepartment of Orthopedics, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Hong XiaGeneral Hospital of Southern Theatre Command of PLA, Guangzhou, 510010, China.
Yu ZhangDepartment of Orthopedics, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Zhigang XuERC for Revolutionizing Metallic Biomaterials, North Carolina A&T State University, Greensboro, NC, 27411, USA.
Yufeng ZhengAcademy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the common alloying elements of Mg, rare earth elements (REEs) have been extensively explored due to their prominent effect on melt purification and mechanical strengthening. However, as for orthopedic applications, the only Mg-RE based implant that has received CE mark approval to date is developed from WE43 alloy, which contains substantial amount of REEs (4 wt% Y and 3 wt% mischmetal) and thus elicited biosafety concerns. Future advancement in novel Mg-RE based alloys is expected to reduce the amount of REEs along with its species. In this study, low amount of Er and Zn (≤3 wt%) were added into Mg. It came out that the addition of Er facilitated grain refinement while Zn contributed to the dynamic recrystallization of alloys. Compared to binary Mg-Er and Mg-Zn alloys, co-addition of Er and Zn could further strengthen the alloys. Among the alloys studied, Mg-1Er-1Zn alloy showed outstanding integrated performance, with relatively uniform corrosion pattern, superior mechanical properties and excellent osteogenic properties, indicating its potential for orthopedic applications. In light of these findings, it is recommended that optimized microstructure regulation and strict control on REEs addition be considered as crucial strategies for further development of novel Mg-RE-Zn alloys as orthopedic implants.

Indexed as

BiocompatibilityBiodegradabilityMg-Er-Zn alloyOrthopedic implantRare-earth

Identifiers

PMID41282410
PMCPMC12637251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.